• BridgeBio Pharma average return on investment for 2023 was -118.4, a 56.82% decline from 2022.
• BridgeBio Pharma average return on investment for 2022 was -75.5, a 13.09% increase from 2021.
• BridgeBio Pharma average return on investment for 2021 was -66.76, a 21.78% increase from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.